Skip to content

Using of Testes Shocker in Improving the Spermatogenesis and Sperms Activity

The Using of the Testes' Shocker in Improving the Sperms' Activity and the Spermatogenesis Process Among Infertile Men

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05506722
Enrollment
250
Registered
2022-08-18
Start date
2022-09-01
Completion date
2023-01-01
Last updated
2022-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthenozoospermia, Infertility Due to Complete Spermatogenic Arrest, Infertility, Male, Infertility Unexplained, Necrospermia, Oligospermia

Keywords

Infertility, Testes shocker, Electric shocks

Brief summary

Infertility was reported in approximately 15% of all heterozygous couples, with male factor accounting for nearly half the cases. This typically occurs due to low sperm production, sperm dysfunction, and sperm delivery obstruction. Etiology of male infertility can be attributed to many factors including acute or chronic illness, accidents, and lifestyle choices.

Detailed description

This study demonstrated that using a painless, convenient at-home device could significantly improve sperm motility and count. This device can be utilized to tackle (for unexplained infertility) the significant issue of infertility in a cost-effective, safe and efficacious.

Interventions

DEVICETestes shocker

It is a device that give electric shocks (up to 5 milli Amperes) and it is designed to contain both the testes within it.

Sponsors

University of Baghdad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

By mixing the devices together and giving them to the participants blindly.

Intervention model description

Double blinded two groups, one is the treated group and the other is the placebo group.

Eligibility

Sex/Gender
MALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Infertile male with oligosperma, necrospermia, asthenozoospermia or hypospermia. Must not taking any drugs or medications for infertility and has nit any congenital diseases in the genital tracts or chronic diseases.

Exclusion criteria

* Have congenial genital tract disease, has a chrome disease, has other than the above mentioned causes for infertility or taking medications that can affect the fertility.

Design outcomes

Primary

MeasureTime frameDescription
Semen analysis4 monthsBy taking the semen from the participants at baseline and then after each month and analyse it.

Countries

Iraq

Contacts

Primary ContactHashim Talib T Hashim, MBChB
hashim.h.t.h@gmail.com+964780257310

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026